Exacerbation of Diabetic Retinopathy following Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Administration: A Case Report

Introduction: Hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitors, used in the treatment of renal anemia, hold the potential to increase the production of vascular endothelial growth factors. Therefore, HIF-PH inhibitors may exacerbate retinal hemorrhage in diseases such as diabetic reti...

Full description

Bibliographic Details

Published in:	Case Reports in Ophthalmology
Main Authors:	Nobuaki Ariyoshi, Fumiaki Higashijima, Makiko Wakuta, Tadahiko Ogata, Manami Ohta, Kazuhiro Kimura
Format:	Article
Language:	English
Published:	Karger Publishers 2024-03-01
Subjects:	hypoxia-inducible factor-prolyl hydroxylase inhibitor vascular endothelial growth factor diabetic retinopathy renal anemia
Online Access:	https://beta.karger.com/Article/FullText/537913